scholarly article | Q13442814 |
P50 | author | Usha Chakravarthy | Q54263391 |
Ruth Hogg | Q56256992 | ||
P2093 | author name string | Balamurali K Ambati | |
Hironori Uehara | |||
Molly McFadden | |||
Michael Taggart | |||
Christina Mamalis | |||
Brian Stagg | |||
Phillip Earle | |||
Samuel Passi | |||
P2860 | cites work | Complement factor H polymorphism in age-related macular degeneration | Q24553334 |
Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab | Q61758502 | ||
Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration | Q64461527 | ||
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers | Q73121134 | ||
Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis | Q73601063 | ||
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers | Q81638207 | ||
Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degeneration | Q83761863 | ||
Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older | Q87372836 | ||
Complement factor H variant increases the risk of age-related macular degeneration | Q28239239 | ||
HTRA1 promoter polymorphism in wet age-related macular degeneration | Q28269561 | ||
Corneal avascularity is due to soluble VEGF receptor-1 | Q28755125 | ||
Seven new loci associated with age-related macular degeneration | Q29416998 | ||
Complement factor H polymorphism and age-related macular degeneration | Q29614931 | ||
Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
Smoking and age-related macular degeneration: a review of association. | Q34449581 | ||
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration | Q34575452 | ||
Serum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular Degeneration | Q34847083 | ||
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis). | Q35676416 | ||
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis | Q35840268 | ||
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis | Q36604482 | ||
Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis | Q36908876 | ||
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. | Q36942442 | ||
Carotenoids and co-antioxidants in age-related maculopathy: design and methods. | Q37344249 | ||
Superoxide dismutase1 levels in North Indian population with age-related macular degeneration | Q37394541 | ||
Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration | Q37395270 | ||
Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study | Q37570185 | ||
A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration | Q37855164 | ||
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. | Q39288785 | ||
New biomarker for neovascular age-related macular degeneration: eotaxin-2. | Q39544638 | ||
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group | Q40440695 | ||
The Wisconsin age-related maculopathy grading system | Q41902806 | ||
Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration | Q42953147 | ||
Predictive model for earlier diagnosis of suspected age-related macular degeneration patients. | Q45941229 | ||
Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: effects on serum VEGF concentration | Q46194066 | ||
Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization | Q46937245 | ||
Association between C-reactive protein and age-related macular degeneration. | Q51051730 | ||
A study on plasma homocysteine level in age-related macular degeneration. | Q51332108 | ||
Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration. | Q54480133 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macular degeneration | Q27429789 |
P304 | page(s) | 92-100.e1-2 | |
P577 | publication date | 2014-10-18 | |
P1433 | published in | American Journal of Ophthalmology | Q4744258 |
P1476 | title | The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration | |
P478 | volume | 159 |
Q39260919 | Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy |
Q33681908 | Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration |
Q47741873 | Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism |
Q64900966 | Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis. |
Q37510227 | Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration |
Q52558418 | Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1. |
Q95803127 | Post-Vitrectomy Endophthalmitis in Victoria, Australia |
Q52728564 | RNA activating-double stranded RNA targeting flt-1 promoter inhibits endothelial cell proliferation through soluble FLT-1 upregulation. |
Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
Q36858963 | Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration |
Q33727486 | Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide |
Q38761425 | The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs |
Search more.